Evidence map›Paper›PMID 18753671›Full record

ArticleDiabetes2008

Bringing light to the dark side of insulin: a journey across the blood-brain barrier.

Robert S Sherwin

Abstract readLecture
In one paragraph

Article in Diabetes, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Your Brain on Insulin: From Heresy to Dogma.Perspectives on psychological science : a journal of the Association for Psychological Science · 2014
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Let the sensor fit the diet.Cell metabolism · 2012
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert S SherwinDepartment of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA. robert.sherwin@yale.edu

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
GLUCOREGULATORY HORMONE INTERACTIONS IN DIABETESR37DK020495 · NIDDK · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 1995 to 2012
$7.3M
Islet Transplantation and CNS Metabolism in HypoglycemiaR01DK072409 · NIDDK · YALE UNIVERSITY · PI SHERWIN, ROBERT STANLEY · 2005 to 2007
$1.3M
NCRR NIH HHS UL1 RR 024139NCRR NIH HHS UL1 RR024139NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK 45735NIDDK NIH HHS R01 DK072409NIDDK NIH HHS R37 DK020495NIDDK NIH HHS R37 DK20495
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBlood-Brain BarrierBlood GlucoseBrain ChemistryDiabetes Mellitus, Type 1HumansHypoglycemiaHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulin

Identifiers

PMID18753671
PMCPMC2518475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.